Description
Fezolinetant represents a significant advancement in the non-hormonal options for managing VMS associated with menopause. This module provides a summary of clinical evidence to support clinicians in identifying patients who are most likely to benefit from fezolinetant, enabling more personalized treatment options for women with VMS.